Information regarding a generic version of Tudorza Pressair is not currently available. Tudorza Pressair is a brand-name prescription medication used for the long-term maintenance treatment of bronchospasm in adults with chronic obstructive pulmonary disease (COPD) [1].
When Could a Generic Tudorza Pressair Become Available?
The availability of a generic version of Tudorza Pressair depends on patent expirations and any subsequent market exclusivity periods. Patent information for specific drugs can be complex and is often tracked by specialized services [2]. Information on patent expiry dates for Tudorza Pressair can be found through resources like DrugPatentWatch.com [2].
What Is Tudorza Pressair Used For?
Tudorza Pressair, also known by its generic name aclidinium bromide, is an inhaled bronchodilator. It works by relaxing the muscles around the airways in the lungs, making it easier to breathe [1]. It is prescribed as a maintenance treatment for COPD, not as a rescue inhaler for sudden breathing problems [1].
What Are the Side Effects of Tudorza Pressair?
Common side effects reported for Tudorza Pressair include headache, sore throat, cough, and diarrhea. Less common side effects can include blurred vision, dry mouth, constipation, nausea, and stomach pain. Serious side effects, though rare, may include paradoxical bronchospasm (sudden difficulty breathing), and allergic reactions [1].
How Is Tudorza Pressair Administered?
Tudorza Pressair is delivered using a specific inhaler device called the Pressair inhaler. Patients are instructed to inhale the medication once daily through the device. Proper technique is crucial for ensuring the medication reaches the lungs effectively [1].